Welcome to CDC Stacks | Cervical Cancer Prevention in HIV-infected Women Using the “See and Treat” Approach in Botswana - 41937 | CDC Public Access
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Cervical Cancer Prevention in HIV-infected Women Using the “See and Treat” Approach in Botswana
Filetype[PDF - 251.01 KB]


Details:
  • Pubmed ID:
    22134146
  • Pubmed Central ID:
    PMC3884088
  • Description:
    Background

    Cervical cancer is a major public health problem in resource-limited settings, particularly among HIV-infected women. Given the challenges of cytology-based approaches, the efficiency of new screening programs need to be assessed.

    Setting

    Community and hospital-based clinics in Gaborone, Botswana.

    Objective

    To determine the feasibility, and efficiency of the “See and Treat” approach using Visual Inspection Acetic Acid (VIA) and Enhanced Digital Imaging (EDI) for cervical cancer prevention in HIV-infected women.

    Methods

    A two-tier community-based cervical cancer prevention program was implemented. HIV-infected women were screened by nurses at the community using the VIA/EDI approach. Low-grade lesions were treated with cryotherapy on the same visit.

    Results

    From March 2009 through January 2011, 2,175 patients were screened for cervical cancer at our community-based clinic. 253 (11.6%) were found to have low-grade lesions and received same-day cryotherapy. 1,347 (61.9%) women were considered to have a normal examination and 575 (27.3%) were referred for further evaluation and treatment. Of the 1,347 women initially considered to have normal exams, 267 (19.8%) were recalled based on weekly quality control assessments. 210 (78.6%) of the 267 recalled women and 499 (86.8%) of the 575 referred women were seen at the referral clinic. Of these 709 women, 506 (71.4%) required additional treatment. Overall, 264 CIN stage 2 or 3 were identified and treated, and six micro-invasive cancers identified were referred for further management.

    Conclusions

    Our “See and Treat” cervical cancer prevention program using the VIA/EDI approach is a feasible, high-output and high-efficiency program, worthy of considering as an additional cervical cancer screening method in Botswana, especially for women with limited access to the current cytology-based screening services.

  • Document Type:
  • Collection(s):
  • Funding:
    P30 AI045008/AI/NIAID NIH HHS/United States
    U2G PS001949/PS/NCHHSTP CDC HHS/United States
    1U2GPS001949/PHS HHS/United States
    IP30 AI 45008/AI/NIAID NIH HHS/United States
No Related Documents.
You May Also Like: